[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336675-105":59,"doc-detail-336675-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","co-delivery-of-docetaxel-and-curcumin-functionalized-mixed-micelles-for-the-treatment-of-drug-resistant-breast-cancer-by-oral-administration","Co-Delivery of Docetaxel and Curcumin Functionalized Mixed Micelles for the Treatment of Drug-Resistant Breast Cancer by Oral Administration","","Mixed micelles were developed for oral co-encapsulation of docetaxel (DTX) and curcumin (CUR) to address toxicity and multidrug resistance in breast cancer chemotherapy. D-α-Tocopherol poly(ethylene glycol) 1000 succinate (TPGS) and soluplus produced (DTX+CUR)-loaded mixed micelles with uniform ~64 nm size, high loading/encapsulation, sustained release, and pH-dependent stability. In vitro studies on MCF-7/Adr cells showed enhanced uptake and apoptosis, with elevated ROS levels. In vivo pharmacokinetics increased oral absorption of DTX versus pure DTX, giving 574% relative oral bioavailability, with efficacy comparable to injected taxotere in resistant tumor-bearing mice.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/co-delivery-of-docetaxel-and-curcumin-functionalized-mixed-micelles-for-the-treatment-of-drug-resistant-breast-cancer-by-oral-administration/336675/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/co-delivery-of-docetaxel-and-curcumin-functionalized-mixed-micelles-for-the-treatment-of-drug-resistant-breast-cancer-by-oral-administration/336675.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What formulation was developed for treating drug-resistant breast cancer?","Question",{"text":113,"@type":114},"The study developed (DTX+CUR)-loaded mixed micelles for oral co-delivery of docetaxel and curcumin using TPGS and soluplus.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the mixed micelles perform in vitro on drug-resistant breast cancer cells?",{"text":118,"@type":114},"On MCF-7/Adr cells, the formulation showed the highest cellular uptake, increased cytotoxicity, higher apoptosis-inducing rates, and elevated ROS levels.",{"name":120,"@type":111,"acceptedAnswer":121},"What was the main in vivo outcome regarding oral absorption and bioavailability?",{"text":122,"@type":114},"In vivo pharmacokinetics showed markedly enhanced oral absorption of DTX compared with pure DTX, with a relative oral bioavailability of 574%.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336675,1790102085,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","International Journal of Nanomedicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article ORIGINAL RESEARCH  \nCo-Delivery of Docetaxel and Curcumin Functionalized Mixed Micelles for the Treatment of Drug-Resistant Breast Cancer by Oral Administration  \nChengyang Dian 1 , Zebin Qian 1 , Mengnan Ran 1 , Xiong Yan 1 , Linghui Dian 1 , 2  \n1School of Pharmaceutical Sciences, Guangdong Medical University, Dongguan, 523808, People’s Republic of China; 2Dongguan Key Laboratory of Screening and Research of Anti-Inflammatory Ingredients in Chinese Medicine, Guangdong Medical University, Dongguan, 523808, People’s Republic of China  \nCorrespondence: Linghui Dian, School of Pharmaceutical Sciences, Guangdong Medical University, Xincheng Road 1, Dongguan, 523808, People’s Republic of China, Tel/Fax +86769 22896560, Email [605911308@qq.com](605911308@qq.com)  \n\n| Background: Chemotherapeutic drugs have some drawbacks in antineoplastic therapy, mainly containing seriously toxic side effects caused by injection and multi-drug resistance (MDR) . Co-delivery with two or more drugs via nanomicelles is a promising strategy to solve these problems. Oral chemotherapy is increasingly preferred owing to its potential to enhance the life quality of patients. Methods and Results: The study intended to develop mixed micelles using D-α-Tocopherol poly(ethylene glycol) 1000 succinate (TPGS) and soluplus for the co-encapsulation of docetaxel (DTX) and curcumin (CUR), marked as (DTX+CUR)-loaded mixed micelles, treating drug-resistant breast cancer by oral administration. The (DTX+CUR)-loaded mixed micelles had a uniform particle size (~64 nm), high drug loading and encapsulation efficiency, in vitro sustained-release properties and good pH-dependent stability. In vitro cell study, the (DTX+CUR)-loaded mixed micelles displayed the highest cellular uptake, cytotoxicity, cell apoptosis-inducing rates and cell ROS-inducing levels on MCF-7/Adr cells. Notably, in vivo pharmacokinetic studies,(DTX+CUR)-loaded mixed micelles enhanced markedly the oral absorption of DTX compared to pure DTX, with a relative oral bioavailability of 574% . The (DTX+CUR)-loaded mixed micelles by oral administration had the same anticancer efficacy as taxotere by injection in resistant breast cancer bearing mice.\u003Cbr>Conclusion: (DTX+CUR)-loaded mixed micelles could provide a potential formulation for treating drug-resistant breast cancers by oral administration.\u003Cbr>Keywords: docetaxel, mixed micelles, resistant breast cancer, oral delivery, bioavailability, mice |\n| --- |\n| Introduction\u003Cbr>Chemotherapy is pivotal in the clinical treatment of various tumors. Traditionally, many chemotherapeutic drugs are administered intravenously, leading to significant adverse reactions.1 In contrast, oral chemotherapy offers numerous benefits, especially for chronic patients, including convenience, cost-effectiveness, pain alleviation, and improved quality of life.2 It enables breast cancer patients to continue treatment at home after initial hospital care. However, the oral administration of most anticancer drugs is hindered by poor gastrointestinal absorption, largely due to the action of P-type glycoproteins (P-gp) in the intestine,3,4 making the improvement of oral bioavailability a critical challenge for successful chemotherapy.\u003Cbr>Docetaxel (DTX) is a widely used chemotherapeutic agent for treating various cancers.5 Its clinical application is limited by poor water solubility and low oral bioavailability.6 Administered intravenously with solvents like tween 80 and ethanol, DTX is associated with severe side effects such as neurotoxicity and neutropenia. The presence of P-gp efflux mechanisms in the gastrointestinal tract and metabolism by cytochrome P-4503A4 further restricts DTX’s ability |\n\nReceived: 6 April 2024  \nAccepted: 14 August 2024  \nPublished: 22 August 2024  \nInternational Journal of Nanomedicine 2024:19 8603–8620 8603  \n© 2024 Dian et al. Thi","cbCaikE07PZIlsIO","https://ap.wps.com/l/cbCaikE07PZIlsIO","pdf",13526886,18,"English","# Background\n# Methods and Results\n# Introduction\n# Conclusion","[{\"question\":\"What formulation was developed for treating drug-resistant breast cancer?\",\"answer\":\"The study developed (DTX+CUR)-loaded mixed micelles for oral co-delivery of docetaxel and curcumin using TPGS and soluplus.\"},{\"question\":\"How did the mixed micelles perform in vitro on drug-resistant breast cancer cells?\",\"answer\":\"On MCF-7/Adr cells, the formulation showed the highest cellular uptake, increased cytotoxicity, higher apoptosis-inducing rates, and elevated ROS levels.\"},{\"question\":\"What was the main in vivo outcome regarding oral absorption and bioavailability?\",\"answer\":\"In vivo pharmacokinetics showed markedly enhanced oral absorption of DTX compared with pure DTX, with a relative oral bioavailability of 574%.\"}]","Co-Delivery of Docetaxel and Curcumin Functionalized Mixed Micelles for the Treatment of Drug-Resistant Breast Cancer by Oral Administration | PDF",1790016128,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b8a48a61a7a4f044dfb0e8519a701db.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2343be1eb0f8bc8ef7f313ef41dc51c1.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd43cfd29934f9d4e321c4c8473ab0e8.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50a099b9d1333cd99a4a8955bae9d5e0.webp",980,1268]